The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,960.00
Bid: 1,969.00
Ask: 1,971.00
Change: 35.00 (1.82%)
Spread: 2.00 (0.102%)
Open: 1,937.00
High: 1,977.00
Low: 1,931.00
Prev. Close: 1,925.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

FTSE quarterly review confirms raft of changes to 100 and 250 indices

Thu, 02nd Jun 2016 08:00

(ShareCast News) - Hikma Pharmaceuticals' promotion to the FTSE 100 index was confirmed after the latest quarterly review was announced overnight, while demoted blue chip Inmarsat was joined in the FTSE 250 by three recently floated finance groups CYBG, CMC Markets and Metro Bank plus several others.Smurfit Kappa, Ascential, Countryside Properties and Hill & Smith were also promoted to the mid-cap index, where along with the other newcomers will be officially added by FTSE Russell on 20 June.As indicated recently, Inmarsat rejoins the mid-cap index after just a year as its shares were hit when the satellite group cut its full-year revenue guidance by $50m amid an ongoing recession in global maritime and energy markets.Demoted from the 250 were Lookers, Melrose Industries, Northgate, Ophir Energy, Interserve, Jimmy Choo and the Highbridge Multi-Strategy Fund.CYBG is the holding company that owns Clydesdale Bank and Yorkshire Bank consumer lending brands, which was floated by National Australia Bank in February. Its shares have surged from their 180p float price, where it had a market capitalisation of £1.58bn, to 275p.Joining in the same month but with a debut valuation of less than half that was CMC Markets, the spreadbetting firm founded by Peter Cruddas in 1989, it has gained ground at a slower rate, rising from an initial 240p to above 270p recently.Metro Bank is a more recently formed challenger bank that had its initial public offer at a price of 2,000p in March after being founded by US businessman Vernon Hill in 2010. It has since risen to 2,241p where it has a capitalisation of £1.8bn.Irish based paper-packaging company Smurfit Kappa was added after changing to a dual listing, with London now its primary listing and Dublin secondary.Another February flotation, Countryside Properties is a housebuilder with high growth aspirations and market leading position in public-sector housing redevelopment. Since listing at a price of 225p and a market cap of £1.01bn, the shares were hiked up above 275p by encouraging interim results in May.Ascential, the publisher formerly known as Emap and Top Right, had 35% of its equity floated in February by private equity firm Apax and Guardian Media at a price of 200p that gave the group an £0.8bn valuation. The shares have since risen to 238p.Hill & Smith Holdings, an infrastructure product and galvanising services provider, has the longest stock market history, having floated in 1969. After an uninspiring decade, since the millennium the shares have surged from around 60p to around 925p, including a leap from just over 400p in the last three years.As indicated by the comments from some, all the companies should expect to see benefits for shareholders and attract new institutional and retail investors."Inclusion in the FTSE 250 Index is another significant milestone for us all at CMC and we look forward to widening our existing strong investor base with new shareholders," said CMC founder and chief executive Peter Cruddas.Smurfit CEO Tony Smurfit said: "We expect our inclusion in the FTSE AllShare to provide an incremental benefit to our shareholders. Over time, our new dual listing arrangement should widen the base of investors eligible to invest in the group while further strengthening the liquidity in our shares."
More News
3 Jan 2023 09:25

Hikma launches version of Xyrem medicine in US for treating narcolepsy

(Alliance News) - Hikma Pharmaceuticals PLC on Tuesday said it launched an authorised generic version of the Xyrem sodium oxybate prescription medicine in the US for treating narcolepsy.

Read more
3 Jan 2023 09:24

LONDON BROKER RATINGS: Citigroup cuts Wizz Air; Redburn likes CRH

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning, Monday and late Friday:

Read more
3 Jan 2023 09:03

LONDON MARKET OPEN: Stocks jump in first session of 2023

(Alliance News) - Stock prices in London made a strong start to the new year on Tuesday, despite weak Chinese data and the UK suffering a fresh wave of rail strikes.

Read more
3 Jan 2023 07:58

LONDON BRIEFING: Stocks called higher; China factory sector shrinks

(Alliance News) - Stocks in London are expected to start a new year on the front foot on Tuesday, after a mixed session in Asia amid weak Chinese economic data.

Read more
3 Jan 2023 07:46

Hikma launches generic narcolepsy solution in US

(Sharecast News) - Hikma Pharmaceuticals has launched an authorised generic version of Jazz Pharmaceuticals' 'Xyrem 1', or sodium oxybate oral solution, it announced on Tuesday.

Read more
8 Dec 2022 09:48

LONDON BROKER RATINGS: JPMorgan cuts Travis Perkins; BofA likes IAG

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
6 Dec 2022 10:48

RBC Capital Markets starts Hikma at 'outperform'

(Sharecast News) - RBC Capital Markets initiated coverage of Hikma Pharmaceuticals on Tuesday at 'outperform' with a 1,750p price target.

Read more
6 Dec 2022 10:26

LONDON BROKER RATINGS: JPMorgan cuts Lloyds but raises Barclays

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
15 Nov 2022 12:10

Credit Suisse initiates coverage of Hikma at 'outperform'

(Sharecast News) - Credit Suisse has initiated coverage of Hikma Pharmaceuticals with an 'outperform' rating.

Read more
15 Nov 2022 09:58

LONDON BROKER RATINGS: Jefferies cuts Aston Martin to 'underperform'

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
14 Nov 2022 09:25

LONDON BROKER RATINGS: Credit Suisse cuts Ferrexpo to 'neutral'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
8 Nov 2022 09:39

LONDON BROKER RATINGS: Peel cuts Persimmon; Liberum raises Hammerson

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
3 Nov 2022 11:17

Hikma Pharmaceuticals reiterates 2022 guidance as costs widen

(Alliance News) - Hikma Pharmaceuticals PLC on Thursday reiterated annual guidance for all three of its businesses, continuing to expect them to underperform against 2021 due to rising costs.

Read more
3 Nov 2022 11:08

With tighter purse strings, is parity less probable for the pound?

STOXX 600 down 1.1%

*

Read more
3 Nov 2022 09:28

Banks, insurance dodge carnage as real estate stocks sink

Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at .

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.